Search Results

There are 808009 results for: content related to: Improvement of actinic keratosis associated with sunitinib therapy for metastatic renal cell carcinoma

  1. You have free access to this content
    Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

    International Journal of Cancer

    Volume 134, Issue 7, 01 April 2014, Pages: 1695–1705, Ritika Jaini, Patricia Rayman, Peter A. Cohen, James H. Finke and Vincent K. Tuohy

    Version of Record online : 8 OCT 2013, DOI: 10.1002/ijc.28488

  2. You have full text access to this Open Access content
    Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells

    Cancer Science

    Volume 104, Issue 8, August 2013, Pages: 1052–1061, Yu Zhu, Le Xu, Jianping Zhang, Xiaoyi Hu, Yujun Liu, Hankun Yin, Tao Lv, Heng Zhang, Li Liu, Huimin An, Haiou Liu, Jiejie Xu and Zongming Lin

    Version of Record online : 16 MAY 2013, DOI: 10.1111/cas.12176

  3. You have free access to this content
    Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy

    International Journal of Cancer

    Volume 130, Issue 8, 15 April 2012, Pages: 1948–1959, Benedetto Farsaci, Jack P. Higgins and James W. Hodge

    Version of Record online : 8 AUG 2011, DOI: 10.1002/ijc.26219

  4. You have free access to this content
    Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma


    Volume 120, Issue 5, 1 March 2014, Pages: 692–701, Petros D. Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn A. Bylow, Steven G. Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al-Hawary, David C. Smith and Maha Hussain

    Version of Record online : 18 NOV 2013, DOI: 10.1002/cncr.28477

  5. You have free access to this content
    Sunitinib Produces Neuroprotective Effect Via Inhibiting Nitric Oxide Overproduction

    CNS Neuroscience & Therapeutics

    Volume 20, Issue 3, March 2014, Pages: 244–252, Wei Cui, Zai-Jun Zhang, Sheng-Quan Hu, Shing-Hung Mak, Da-Ping Xu, Chung-Lit Choi, Yu-Qiang Wang, Wah-Keung Tsim, Ming-Yuen Lee, Jian-Hui Rong and Yi-Fan Han

    Version of Record online : 7 JAN 2014, DOI: 10.1111/cns.12203

  6. Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer


    Volume 13, Issue 23-24, December 2013, Pages: 3554–3562, Jin-Gyun Lee, Kimberly Q. McKinney, Jean-Luc Mougeot, Herbert L. Bonkovsky and Sun-Il Hwang

    Version of Record online : 25 NOV 2013, DOI: 10.1002/pmic.201300248

  7. You have free access to this content
    Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation

    BJU International

    Volume 112, Issue 2, July 2013, Pages: E211–E220, Iori Sakai, Hideaki Miyake and Masato Fujisawa

    Version of Record online : 10 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11655.x

  8. Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 56, Issue 8, 30 June 2013, Pages: 392–395, T. M. Sakr, D. M. El-Safoury, Gehanne A. S. Awad and M. A. Motaleb

    Version of Record online : 22 MAY 2013, DOI: 10.1002/jlcr.3060

  9. Sunitinib-induced hyperammonaemia in a patient with pancreatic neuroendocrine tumour

    Journal of Clinical Pharmacy and Therapeutics

    Volume 38, Issue 4, August 2013, Pages: 327–329, Y.-f. Shea, W.-y. J. Chiu, M.-y. M. Mok, I. F.-n. Hung and C.-c. T. Yau

    Version of Record online : 16 APR 2013, DOI: 10.1111/jcpt.12054

  10. You have free access to this content
    Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α

    BJU International

    Volume 112, Issue 1, July 2013, Pages: 32–38, Ilya Tsimafeyeu, Janie S. Zart and Bin Chung

    Version of Record online : 7 JUN 2013, DOI: 10.1111/bju.12107

  11. You have free access to this content
    A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061


    Volume 120, Issue 8, 15 April 2014, Pages: 1194–1202, Michelle A. Rudek, Page C. Moore, Ronald T. Mitsuyasu, Bruce J. Dezube, David Aboulafia, John Gerecitano, Ryan Sullivan, Mary E. Cianfrocca, David H. Henry, Lee Ratner, Missak Haigentz, Afshin Dowlati, Richard F. Little, Susan Percy Ivy and John F. Deeken

    Version of Record online : 28 JAN 2014, DOI: 10.1002/cncr.28554

  12. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Version of Record online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  13. The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China

    The Clinical Respiratory Journal

    Volume 8, Issue 2, April 2014, Pages: 206–212, You-ru Liu, Wei Zhu, Jian-liang Zhang, Jia-qi Huang, Yi-zhuo Zhao, Wei Zhang, Bao-hui Han, Yi-hong Yao, Li-yan Jiang and Shan-qun Li

    Version of Record online : 11 DEC 2013, DOI: 10.1111/crj.12059

  14. You have full text access to this OnlineOpen article
    Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1003–1015, Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman and Victor L. Thijssen

    Version of Record online : 31 MAR 2015, DOI: 10.1002/cam4.441

  15. You have full text access to this OnlineOpen article
    Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment

    Cancer Science

    Volume 106, Issue 2, February 2015, Pages: 160–170, Gökçe Hatipoglu, Stefan W. Hock, Ruth Weiss, Zheng Fan, Tina Sehm, Ali Ghoochani, Michael Buchfelder, Nicolai E. Savaskan and Ilker Y. Eyüpoglu

    Version of Record online : 15 FEB 2015, DOI: 10.1111/cas.12580

  16. You have full text access to this OnlineOpen article
    Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants

    Cancer Science

    Volume 105, Issue 1, January 2014, Pages: 117–125, Jie Zhao, Haitian Quan, Yongping Xu, Xiangqian Kong, Lu Jin and Liguang Lou

    Version of Record online : 4 JAN 2014, DOI: 10.1111/cas.12320

  17. You have full text access to this Open Access content
    Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene

    Cancer Science

    Volume 101, Issue 6, June 2010, Pages: 1493–1500, Haruka Kawahara, Kohji Noguchi, Kazuhiro Katayama, Junko Mitsuhashi and Yoshikazu Sugimoto

    Version of Record online : 22 FEB 2010, DOI: 10.1111/j.1349-7006.2010.01539.x

  18. You have free access to this content
    Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 132–144, Aiping ZHOU

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01525.x

  19. Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 472–481, Reza Khosravan, Melvin Toh, May Garrett, JoAnn La Fargue, Grace Ni, Thomas C. Marbury, Suzanne K. Swan, Norman M. Lunde and Carlo L. Bello

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009347868

  20. You have free access to this content
    Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials

    International Journal of Cancer

    Volume 135, Issue 4, 15 August 2014, Pages: 763–773, Matteo Santoni, Alessandro Conti, Ugo De Giorgi, Roberto Iacovelli, Francesco Pantano, Luciano Burattini, Giovanni Muzzonigro, Rossana Berardi, Daniele Santini and Stefano Cascinu

    Version of Record online : 18 NOV 2013, DOI: 10.1002/ijc.28544